Image

Middle East and Africa Respiratory Diagnostics Market – Industry Trends and Forecast to 2027

  • Medical Devices
  • Published Report
  • Nov 2020
  • MEA
  • 350 Pages
  • No of Tables: 119
  • No of Figures: 55

Middle East and Africa Respiratory Diagnostics Market, By Product & Services (Instruments and Devices, Assays and Reagents, Services and Software), Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests), Diseases (Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Asthma, Tuberculosis, Bronchitis, Pulmonary Fibrosis, Other Diseases), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users), Distribution Channel (Direct Tender, Retail Sales, Other), Country (Saudi Arabia, U.A.E., Egypt, Israel, South Africa and Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Middle East and Africa Respiratory Diagnostics MarketMarket Analysis and Insights : Middle East and Africa Respiratory Diagnostics Market

The respiratory diagnostics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.3% in the forecast period of 2020 to 2027 and expected to reach 2,300.93 million by 2027.

Increases case of chronic diseases and increasing geriatric population are the major drivers of market which propelled the demand of the market in the forecast period. Respiratory diagnostics play an important role in maintaining the overall population health. Respiratory diseases are varied and range from simple allergies to fatal conditions.

A large number of respiratory diseases are infectious and hence the need for diagnosis and treating it becomes more important. Moreover, the increasing focus on lung cancer is also playing an important role in the growth of the market. The demand for rapid tests for respiratory illnesses is also gaining immense significance in the region due to large population.

The respiratory diagnostics market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Respiratory Diagnostics MarketRespiratory Diagnostics Market Scope and Market Size

The respiratory diagnostics market is segmented on the basis of product & services, test type, diseases, end user, distribution channel. The growth among segments helps you to analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product & services, the respiratory diagnostics market is segmented into instruments and devices, assays and reagents and services and software. In 2020, instruments and devices segment is dominating the respiratory diagnostics market because as the prevalence of respiratory diseases increases, the continuous need of diagnostics instruments and devices also increases in the laboratories and home healthcare diagnosis.
  • On the basis of test type, the respiratory diagnostics market is segmented into traditional diagnostic tests, mechanical tests, imaging tests and molecular diagnostic tests. In 2020, traditional diagnostic tests segment is dominating the respiratory diagnostics market because traditional diagnostic tests are widely used by the developing countries and quick work time of these tests allow patients to get effective results at less span of time which further improves the treatment procedure.
  • On the basis of diseases, the respiratory diagnostics market is segmented into chronic obstructive pulmonary disease (COPD), lung cancer, asthma, tuberculosis, bronchitis, pulmonary fibrosis and other diseases. In 2020, chronic obstructive pulmonary disease (COPD) segment is dominating the respiratory diagnostics market because of increasing indoor & outdoor air pollution, cigarettes smoking and tobacco consumption and globally 3.17 million deaths were caused by chronic obstructive pulmonary disease (COPD) only.
  • On the basis of end user, the respiratory diagnostics market is segmented into hospital/clinical laboratories, physician offices, reference laboratories and other end users. In 2020, hospital/clinical laboratories segment is dominating the respiratory diagnostics market because hospitals and clinical laboratories are the first and primary place for the diagnosis of respiratory diseases due to their complex nature and required trained professionals and advanced technology for diagnosis.
  • On the basis of distribution channel, the respiratory diagnostics market is segmented into direct tender, retail sales and other. In 2020, direct tender segment is dominating the respiratory diagnostics market because the instruments and devices used for the diagnosis of respiratory diseases are too costly and can be purchased via direct tenders, after comparing the price and efficacy of the products.

Respiratory Diagnostics Market Country Level Analysis

The respiratory diagnostics market is analysed and market size information is provided by product & services, test type, disease, end user, distribution channel.

The countries covered in the respiratory diagnostics market report are Saudi Arabia, U.A.E., Egypt, Israel, South Africa and Rest of Middle East and Africa.

The respiratory diagnostics market is growing primarily due to increasing focus on the high prevalence of the disorders among old aged group. The rising social media concerns are also acting as significant growth factors for the market in Germany, which is the dominant country in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as sales, FDA approvals, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of branded and generic drug manufacturers and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Continuous Advance in Technological Services is Propelling the Market Growth

The respiratory diagnostics market also provides you with detailed market analysis for every country growth with changes in regulatory scenarios with their support for the respiratory diagnostics market. The data is available for historic period 2010 to 2018.

Competitive Landscape and elderly care Market Share Analysis

Respiratory diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to respiratory diagnostics market.

The major companies providing respiratory diagnostics are GE Healthcare (a subsidiary of GENERAL ELECTRIC COMPANY), Koninklijke Philips N.V., Medtronic, BD, COSMED srl, Abbott, F. Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION, Drägerwerk AG & Co. KGaA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., MGC Diagnostics Corporation, Masimo, bioMérieux SA, Carestream Health, VYAIRE, Seegene Inc., ResMed, SDI Diagnostics, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch, approval, partnership and agreement are also initiated by the companies’ worldwide which are also accelerating the respiratory diagnostics market.

  • In September 2020, Abbott launched Panbio COVID-19 Rapid Test in France for supporting the detection of rapidly rising COVID-19 patients in France. This launch of diagnostic test by the company has increased its credibility in the market.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the respiratory diagnostics market which also provides the benefit for organisation to improve their offering for respiratory diagnostics.

Customization Available: Middle East and Africa Respiratory Diagnostics Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 RESPIRATORY DISEASES WORLDWIDE HEALTH BURDEN, IN 2019

TABLE 2 FDA RECALL PRODUCT

TABLE 3 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 4 FEDERAL SPENDING AND TAX EXPENDITURE FOR HEALTHCARE, IN 2018

TABLE 5 COMPOSITION OF FEDERAL SPENDING ON HEALTHCARE, IN THE U.S.

TABLE 6 MIDDLE EAST AND AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2019-2027 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA PRODUCT & SERVICES FOR RESPIRATORY CONDITIONS IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA INSTRUMENTS AND DEVICES IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA ASSAYS AND REAGENTS IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA ASSAYS AND REAGENTS IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA SERVICES AND SOFTWARE IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA TRADITIONAL DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA TRADITIONAL DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA MECHANICAL TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA MECHANICAL TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA OBSTRUCTIVE SLEEP APNOEA (OSA) DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA IMAGING TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA IMAGING TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTIC TESTSIN TEST TYPE IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY DISEASES 2019-2027 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA ASTHMA IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA LUNG CANCER IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA TUBERCULOSIS IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA BRONCHITIS IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA PULMONARY FIBROSIS IN RESPIRATOORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA OTHERS IN RESPIRATOORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY END USER 2019-2027 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA HOSPITAL/CLINICAL LABORATORIES IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA PHYSICIAN OFFICES IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA REFERENCE LABORATORIES IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA OTHER END USERS IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 2019-2027 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA DIRECT TENDER IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA RETAIL SALES IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA OTHERS IN RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA INSTRUMENTS AND DEVICES IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICAASSAYS AND REAGENTS IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA TRADITIONAL DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA MECHANICAL TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA PULMONARY FUNCTION TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA OBSTRUCTIVE SLEEP APNOEA (OSA) DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA MAGING TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 53 MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 54 SOUTH AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 55 SOUTH AFRICA INSTRUMENTS AND DEVICES IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 56 SOUTH AFRICA ASSAYS AND REAGENTS IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 57 SOUTH AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 58 SOUTH AFRICA TRADITIONAL DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 59 SOUTH AFRICA MECHANICAL TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 60 SOUTH AFRICA PULMONARY FUNCTION TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 61 SOUTH AFRICA OBSTRUCTIVE SLEEP APNOEA (OSA) DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 62 SOUTH AFRICA IMAGING TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 63 SOUTH AFRICA MOLECULAR DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 64 SOUTH AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 65 SOUTH AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 66 SOUTH AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 67 SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 68 SAUDI ARABIA INSTRUMENTS AND DEVICES IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 69 SAUDI ARABIA ASSAYS AND REAGENTS IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 70 SAUDI ARBIA RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 71 SAUDI ARABIA TRADITIONAL DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 72 SAUDI ARABIA MECHANICAL TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 73 SAUDI ARABIA PULMONARY FUNCTION TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 74 SAUDI ARABIA OBSTRUCTIVE SLEEP APNOEA (OSA) DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 75 SAUDI ARABIA IMAGING TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 76 SAUDI ARABIA MOLECULAR DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 77 SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 78 SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 79 SOUTH AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 80 UAE RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 81 UAE INSTRUMENTS AND DEVICES IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 82 UAE ASSAYS AND REAGENTS IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 83 UAE RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 84 UAE TRADITIONAL DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 85 UAE MECHANICAL TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 86 UAE PULMONARY FUNCTION TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 87 UAE OBSTRUCTIVE SLEEP APNOEA (OSA) DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 88 UAE IMAGING TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 89 UAE MOLECULAR DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 90 UAE RESPIRATORY DIAGNOSTICS MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 91 UAE RESPIRATORY DIAGNOSTICS MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 92 UAE RESPIRATORY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 93 EGYPT RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 94 EGYPT INSTRUMENTS AND DEVICES IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 95 EGYPT ASSAYS AND REAGENTS IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 96 EGYPT RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 97 EGYPT TRADITIONAL DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 98 EGYPT MECHANICAL TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 99 EGYPT PULMONARY FUNCTION TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 100 EGYPT OBSTRUCTIVE SLEEP APNOEA (OSA) DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 101 EGYPT IMAGING TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 102 EGYPT MOLECULAR DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 103 EGYPT RESPIRATORY DIAGNOSTICS MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 104 EGYPT RESPIRATORY DIAGNOSTICS MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 105 EGYPT RESPIRATORY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 106 ISRAEL RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 107 ISRAEL INSTRUMENTS AND DEVICES IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 108 ISRAEL ASSAYS AND REAGENTS IN RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

TABLE 109 ISRAEL RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 110 ISRAEL TRADITIONAL DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 111 ISRAEL MECHANICAL TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 112 ISRAEL PULMONARY FUNCTION TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 113 ISRAEL OBSTRUCTIVE SLEEP APNOEA (OSA) DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 114 ISRAEL IMAGING TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 115 ISRAEL MOLECULAR DIAGNOSTIC TESTS IN RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 116 ISRAEL RESPIRATORY DIAGNOSTICS MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 117 ISRAEL RESPIRATORY DIAGNOSTICS MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 118 ISRAEL RESPIRATORY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 119 REST OF MIDDLE EAST AND AFRICA RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions